메뉴 건너뛰기
Current Pharmacogenomics and Personalized Medicine
Volumn 8, Issue 1, 2010, Pages 1-3
Pharmacogenovigilance - An idea whose time has come
Author keywords

[No Author keywords available]
Indexed keywords

ALERTNESS; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; EDITORIAL; HUMAN; PHARMACEUTICAL CARE; PHARMACOGENETICS; PHARMACOGENOMICS; POSTMARKETING SURVEILLANCE;
EID: 77950212493     PISSN: 18756921     EISSN: 18756913     Source Type: Journal    
DOI: 10.2174/1875692111008010001     Document Type: Editorial
Times cited : (8)
References (15)
  • 1
    • 0032522873 scopus 로고    scopus 로고
    • Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies
    • Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205
    • (1998) JAMA , vol.279 , pp. 1200-1205
    • Lazarou, J.1    Pomeranz, B.H.2    Corey, P.N.3
  • 2
    • 0031012726 scopus 로고    scopus 로고
    • The costs of adverse drug events in hospitalized patients
    • Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. JAMA 1997; 277: 307-311
    • (1997) JAMA , vol.277 , pp. 307-311
    • Bates, D.W.1    Spell, N.2    Cullen, D.J.3
  • 3
    • 34548602369 scopus 로고    scopus 로고
    • Serious adverse drug events reported to the Food and Drug Administration, 1998-2005
    • Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch Intern Med 2007; 167: 1752-1759
    • (2007) Arch Intern Med , vol.167 , pp. 1752-1759
    • Moore, T.J.1    Cohen, M.R.2    Furberg, C.D.3
  • 4
    • 0142023879 scopus 로고    scopus 로고
    • Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: First results from the research on adverse drug events and reports project
    • Ladewski LA, Belknap SM, Nebeker JR, et al. Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: First results from the research on adverse drug events and reports project. J Clin Oncol 2003; 21: 3859-3866
    • (2003) J Clin Oncol , vol.21 , pp. 3859-3866
    • Ladewski, L.A.1    Belknap, S.M.2    Nebeker, J.R.3
  • 7
    • 69849112772 scopus 로고    scopus 로고
    • Pharma-covigilance of biopharmaceuticals: Challenges remain
    • Giezen TJ, Mantel-Teeuwisse AK, Leufkens HG. Pharma-covigilance of biopharmaceuticals: challenges remain. Drug Saf 2009; 32: 811-817
    • (2009) Drug Saf , vol.32 , pp. 811-817
    • Giezen, T.J.1    Mantel-Teeuwisse, A.K.2    Leufkens, H.G.3
  • 8
    • 77950531315 scopus 로고    scopus 로고
    • Discovery and management of adverse drug reactions: The nomifensine hypersensitivity syndrome, 1977-1986
    • Epub ahead of print, November 5 [doi:10. 1093/shm/hkp049]
    • Abraham J, Davis C. Discovery and management of adverse drug reactions: The nomifensine hypersensitivity syndrome, 1977-1986. Soc Hist Med 2009 [Epub ahead of print, November 5]; doi:10. 1093/shm/hkp049.
    • (2009) Soc Hist Med
    • Abraham, J.1    Davis, C.2
  • 9
    • 0001611165 scopus 로고
    • Incidence of alkaptonuria: A study in chemical individuality
    • Garrod AE. Incidence of alkaptonuria: A study in chemical individuality. Lancet 1902; 2: 653-656
    • (1902) Lancet , vol.2 , pp. 653-656
    • Garrod, A.E.1
  • 10
    • 0035861049 scopus 로고    scopus 로고
    • Potential role of pharma-cogenomics in reducing adverse drug reactions: A systematic review
    • Phillips KA, Veenstra DL, Oren E, et al. Potential role of pharma-cogenomics in reducing adverse drug reactions: a systematic review. JAMA 2001; 286: 2270-2279
    • (2001) JAMA , vol.286 , pp. 2270-2279
    • Phillips, K.A.1    Veenstra, D.L.2    Oren, E.3
  • 11
    • 63849202760 scopus 로고    scopus 로고
    • Pharmacogenetics and pharmacovigilance
    • Howland RH. Pharmacogenetics and pharmacovigilance. Drug Saf 2009; 32: 265-270
    • (2009) Drug Saf , vol.32 , pp. 265-270
    • Howland, R.H.1
  • 12
    • 63849266048 scopus 로고    scopus 로고
    • Spontaneous ADR reports as a trigger for pharmacogenetic research: A prospective observational study in the Netherlands
    • van Puijenbroek E, Conemans J, van Grootheest K. Spontaneous ADR reports as a trigger for pharmacogenetic research: a prospective observational study in the Netherlands. Drug Saf 2009; 32: 255-264
    • (2009) Drug Saf , vol.32 , pp. 255-264
    • Van Puijenbroek, E.1    Conemans, J.2    Van Grootheest, K.3
  • 13
    • 65949092560 scopus 로고    scopus 로고
    • Spontaneous reports and pharmacogenetics: The role of the pharmacovigilance centre
    • van Puijenbroek E, Conemans J, van Grootheest K. Spontaneous reports and pharmacogenetics: the role of the pharmacovigilance centre. Drug Saf 2009; 32: 357-358
    • (2009) Drug Saf , vol.32 , pp. 357-358
    • Van Puijenbroek, E.1    Conemans, J.2    Van Grootheest, K.3
  • 14
    • 33646183685 scopus 로고    scopus 로고
    • How the US drug safety system should be changed
    • Strom BL. How the US drug safety system should be changed. JAMA 2006; 295(17): 2072-2075
    • (2006) JAMA , vol.295 , Issue.17 , pp. 2072-2075
    • Strom, B.L.1
  • 15
    • 70449136457 scopus 로고
    • Drug reactions, enzymes and biochemical genetics
    • Motulsky AG. Drug reactions, enzymes and biochemical genetics. JAMA 1957; 165: 835-837
    • (1957) JAMA , vol.165 , pp. 835-837
    • Motulsky, A.G.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.